Not Yet Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm
NCT07009158
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
Ketamine Assisted Psychotherapy to Improve Quality of Life in Veterans and Civilians With Comorbid Chronic Pain and Posttraumatic Stress Disorder: an Open-label Randomized Controlled Trial.
Sponsor: Kingston Health Sciences Centre
Conditions
Chronic Pain Posttraumatic Stress Disorder (PTSD)
Interventions
Ketamine Infusion Mindfulness-based cognitive therapy
Updated 1 time since 2025 Last updated: May 28, 2025 Started: Oct 31, 2025 Primary completion: Sep 30, 2029 Completion: Sep 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1/PHASE2 trial investigates Chronic Pain and Posttraumatic Stress Disorder (PTSD) and is currently actively recruiting participants. Kingston Health Sciences Centre leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1/PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Kingston Health Sciences Centre
- Providence Care Hospital, Kingston, ON, Canada
- Queen's University
Data source: Queen's University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.